Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Annals of Medicine
|
June 23, 2025
TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis
Si Hyoung Kim, Mi Young Yoon, Sang Sun Yoon
Endocrine
|
May 19, 2019
Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Anticancer Research
|
November 7, 2018
Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Biochemical and Biophysical Research Communications
|
January 29, 2023
Effect of paclitaxel priming on doxorubicin penetration in a multicellular layer model of human colorectal cancer cells
Kwang-Seock Kim, Si Hyoung Kim, Chang-Nim Im, et al.
Anticancer Research
|
October 28, 2020
Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells
Si Hyoung Kim, Yun Kyung Cho, Ji Hye Huh, et al.
Anticancer Research
|
December 6, 2015
Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 30, 2016
Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 7, 2017
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Endocrine
|
December 30, 2017
Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 2, 2017
Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Annals of Medicine
|
June 23, 2025
TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis
Si Hyoung Kim, Mi Young Yoon, Sang Sun Yoon
Endocrine
|
May 19, 2019
Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Anticancer Research
|
November 7, 2018
Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Biochemical and Biophysical Research Communications
|
January 29, 2023
Effect of paclitaxel priming on doxorubicin penetration in a multicellular layer model of human colorectal cancer cells
Kwang-Seock Kim, Si Hyoung Kim, Chang-Nim Im, et al.
Anticancer Research
|
October 28, 2020
Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells
Si Hyoung Kim, Yun Kyung Cho, Ji Hye Huh, et al.
Anticancer Research
|
December 6, 2015
Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 30, 2016
Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 7, 2017
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Endocrine
|
December 30, 2017
Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 2, 2017
Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Page
of 3